Therapies nearing late-stage readouts for COVID-19: Data Byte

Nearly 30 therapeutic candidates for COVID-19 could report their first late-stage data in the next few months, according to BioCentury’s COVID-19 Clinical Trials Dashboard. 

As of Feb. 8, there were almost 200 active Phase III and IV trials of COVID-19 therapies listed in public databases with estimated end dates or milestones between Feb. 1 and Apr. 30. Of these, 36 are testing therapeutics that have yet to yield late-stage data in the indication. ...